Alimera Sciences reported $62.1M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Aerie Pharmaceuticals AERI:US $ 355.53M 7.2M
Alimera Sciences ALIM:US $ 62.1M 16.52M
Applied Genetic Technologies AGTC:US $ 126.97M 2.7M
Bayer BAYN:GR € 114427M 4350M
Insmed INSM:US $ 1.23B 537.39M
Novartis NOVN:VX SF 124015M 2263M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M